APA (7th ed.) Citation

Åkerblom, A., Wojdyla, D., Steg, P. G., Wallentin, L., James, S. K., Budaj, A., . . . Becker, R. C. (2019). Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Journal of thrombosis and thrombolysis, 48(4), . https://doi.org/10.1007/s11239-019-01938-2

Chicago Style (17th ed.) Citation

Åkerblom, Axel, et al. "Prevalence and Relevance of Abnormal Glucose Metabolism in Acute Coronary Syndromes: Insights from the PLATelet Inhibition and Patient Outcomes (PLATO) Trial." Journal of Thrombosis and Thrombolysis 48, no. 4 (2019). https://doi.org/10.1007/s11239-019-01938-2.

MLA (9th ed.) Citation

Åkerblom, Axel, et al. "Prevalence and Relevance of Abnormal Glucose Metabolism in Acute Coronary Syndromes: Insights from the PLATelet Inhibition and Patient Outcomes (PLATO) Trial." Journal of Thrombosis and Thrombolysis, vol. 48, no. 4, 2019, https://doi.org/10.1007/s11239-019-01938-2.